Perspective Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-3.9M | $-4.4M | $479.0K | $290.0K |
| FY2017 | $-5.7M | $-6.3M | $549.0K | $372.0K |
| FY2018 | $-5.7M | $-6.0M | $337.0K | $404.0K |
| FY2019 | $-5.0M | $-5.5M | $444.0K | $420.0K |
| FY2020 | $-3.6M | $-3.9M | $273.0K | $495.0K |
| FY2021 | $-2.8M | $-3.2M | $381.0K | $386.0K |
| FY2022 | $-7.7M | $-10.7M | $266.0K | $983.0K |
| FY2023 | $-36.9M | $-38.0M | $1.1M | $3.7M |
| FY2024 | $-18.3M | $-72.7M | $54.4M | $5.4M |
| FY2025 | $-82.5M | $-95.2M | $12.7M | $9.0M |